Wednesday 4 November | |
GCP Student Living PLC | AGM |
Investment Co PLC | AGM |
Wilmington PLC | AGM |
JPMorgan Global Growth & Income PLC | AGM |
Remote Monitored Systems PLC | GM re Pharm2Farm Ltd acquisition |
Thursday 5 November | |
Arc Minerals Ltd | AGM |
Panthera Resources PLC | AGM |
PCI-PAL PLC | AGM |
Scancell Holdings PLC | adjourned GM re Redmile Funds convertible loan financing |
Friday 6 November | |
Redrow PLC | AGM |
Adriatic Metals PLC | AGM |
Monday 9 November | |
Angus Energy PLC | GM re equity fundraise |
Tuesday 10 November | |
Pacific Horizon Investment Trust PLC | AGM |
Harvest Minerals Ltd | AGM |
Gulf Marine Services PLC | GM re Seafox resolutions for director changes |
Mid Wynd International Investment Trust PLC | AGM |
Copyright 2020 Alliance News Limited. All Rights Reserved. |
Scancell gets go-ahead for UK second phase trials of 'SCIB1'
(Sharecast News) - Cancer immunotherapy developer Scancell Holdings has received all of the UK regulatory, ethical and legal approvals required to initiate the phase 2 clinical trial to assess the safety and efficacy of 'SCIB1' in metastatic melanoma patients also receiving the checkpoint inhibitor pembrolizumab (Keytruda), it announced on Thursday.
Read more